Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Chi Leung Chiang"'
Publikováno v:
Cancers
Volume 15
Issue 4
Pages: 1105
Volume 15
Issue 4
Pages: 1105
This study aims to investigate the association of pre-treatment multi-phasic MR-based radiomics and dosimetric features with treatment response to a novel sequential trans-arterial chemoembolization (TACE) plus stereotactic body radiotherapy (SBRT) p
Autor:
Chi-Leung Chiang, Keith Wan-Hang Chiu, Francis Ann-Shing Lee, Feng-Ming Spring Kong, Albert Chi-Yan Chan
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
Immunotherapy has achieved modest clinical activity in HCC patients. Propensity score matching analysis was conducted to compare the efficacy and safety of combined stereotactic SBRT-IO versus TACE in patients with locally advanced HCC in a tertiary
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Frontiers in Oncology
Frontiers in Oncology
Background: Current treatments of unresectable hepatocellular carcinoma (HCC) are trans-arterial chemo-embolization (TACE), stereotactic body radiotherapy (SBRT), and targeted therapy. However, these treatments are limited in efficacy and safety for
Publikováno v:
JAMA Network Open
Key Points Question Is pembrolizumab a cost-effective second-line therapy for advanced hepatocellular carcinoma from the US perspective? Findings In this economic evaluation of data from the KEYNOTE-240 randomized trial, the incremental number of qua
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Background: Current treatments of unresectable hepatocellular carcinoma (HCC) are trans-arterial chemo-embolization (TACE), stereotactic body radiotherapy (SBRT), and targeted therapy. However, these treatments are limited in efficacy and safety for
Externí odkaz:
https://doaj.org/article/b391c93337ac493686b5b7a93c3da069